- Home
- Products
Besremi (Ropeginterferon alfa-2b-njft)
Besremi (Ropeginterferon alfa-2b-njft)
- Medicine Name: BESREMI
- Generic Name: Ropeginterferon alfa-2b-njft
- Dosage Form & Strength: Injection – 500 mcg/mL solution in a prefilled single-dose syringe
- Manufactured By: PharmaEssentia Corporation
BESREMi is an interferon alfa-2b therapy used for the treatment of adults with polycythemia vera (PV), a rare chronic blood disorder characterized by the overproduction of red blood cells.
Recommended Dosage:
- Starting dose: 100 mcg every 2 weeks by subcutaneous injection
- For patients receiving hydroxyurea: start at 50 mcg
- Increase by 50 mcg every 2 weeks (maximum: 500 mcg) until blood counts stabilize
- Dose modifications or interruption may be required based on tolerability and lab parameters
Neuropsychiatric Reactions: Serious psychiatric events (including depression and suicidal ideation) may occur. Assess for mental health status before and during treatment. Discontinue in severe cases.
Endocrine Toxicity: Avoid in patients with serious or uncontrolled autoimmune endocrine disorders. Monitor thyroid function if symptoms arise.
Blood Count Suppression: Monitor complete blood counts (CBCs) routinely. Risk of anemia, leukopenia, and thrombocytopenia.
Hyperlipidemia: Check serum triglycerides prior to and during therapy. Manage elevations appropriately.
Pregnancy: May cause fetal harm. Pregnancy testing is recommended prior to starting therapy in females of reproductive potential.
To legally import BESREMi into India via Global Rare Meds, the following documentation is necessary:
Required Documentation:
- Valid prescription from a certified hematologist or oncologist
- Diagnostic reports confirming polycythemia vera
- Patient’s government-issued ID
- Import permit (if applicable)
Availability in India:
BESREMi is not commercially available in Indian pharmacies. Global Rare Meds facilitates its import on a named-patient basis in cities such as Mumbai, Delhi, Hyderabad, Bengaluru, Pune, Kolkata, Chennai, Ahmedabad, and others.
📧 Email: info@globalraremeds.com
📞 Call / WhatsApp: +91-99675 15602
Global Rare Meds helps patients access BESREMi through verified global channels:
- Sourced from countries like USA, Canada, Europe, and Australia
- Dispensed only against valid medical prescriptions
- Packaging and cold-chain logistics managed from our fulfillment center in Ambernath, Thane District
- Delivery available across India and select international regions
Q1: What is the generic name of BESREMi?
A: The generic name is Ropeginterferon alfa-2b-njft.
Q2: Who manufactures BESREMi?
A: BESREMi is manufactured by PharmaEssentia Corporation.
Q3: What is BESREMi approved for?
A: BESREMi is approved by the U.S. FDA (November 12, 2021) for the treatment of polycythemia vera in adult patients.
Q4: How is BESREMi supplied?
A: As a single-dose prefilled syringe with 500 mcg/mL solution, intended for subcutaneous administration.
Q5: What are common side effects of BESREMi?
A: Common side effects include fatigue, flu-like symptoms, joint pain, musculoskeletal pain, nasopharyngitis, and pruritus.
Q6: What are the storage instructions?
A: Store BESREMi in a refrigerator at 2°C to 8°C (36°F to 46°F). Protect from light and do not freeze.
Q7: Is BESREMi available in India?
A: BESREMi is not freely available in India but can be imported legally via Global Rare Meds with a valid prescription.
Q8: How much does BESREMi cost in India?
A: Prices vary depending on country of origin and quantity. For a current quote, call +91-99675 15602 or email info@globalraremeds.com
Q9: Can I order BESREMi online in India?
A: Yes, BESREMi can be legally ordered through Global Rare Meds with full compliance and verified international sourcing.
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
